SCHEMBL1978995

SCHEMBL1978995

c1ccc2c(c1)c1cccc3c4ccccc4c4c5c6ccccc6c6cccc7c8ccccc8c(c2c4c13)c5c76

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 8/20 0.58
ALDH1A1 P00352 6/20 0.58
HSD17B10 Q99714 6/20 0.58
HPGD P15428 5/20 0.58
THRB P10828 2/20 0.58
HPRT1 P00492 1/20 0.40
TSHR P16473 5/20 0.39
MAPK1 P28482 2/20 0.39
CASP1 P29466 2/20 0.39
ERBB2 P04626 1/20 0.39
FYN P06241 1/20 0.39
MAOA P21397 1/20 0.39
ACHE P22303 1/20 0.39
AHR P35869 1/20 0.39
HIF1A Q16665 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CYP2A6 P11509 6/20 0.37
TDP1 Q9NUW8 3/20 0.37
CYP3A4 P08684 2/20 0.35
IDO1 P14902 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5471214 1.00 CYP1A2 (0.58) CYP1A2ALDH1A1HSD17B10HPGDTHRB
SCHEMBL5478700 1.00 CYP1A2 (0.58) CYP1A2ALDH1A1HSD17B10HPGDTHRB
SCHEMBL2537906 0.97 CYP1A2 (0.55) CYP1A2ALDH1A1HSD17B10HPGDTHRB
SCHEMBL5471846 0.93 HSD17B10 (0.50) CYP1A2ALDH1A1HSD17B10HPGDTHRB
SCHEMBL5471145 0.93 CYP1A2 (0.58) CYP1A2ALDH1A1HSD17B10HPGDTHRB
SCHEMBL5476671 0.93 HSD17B10 (0.50) CYP1A2ALDH1A1HSD17B10HPGDTHRB
SCHEMBL2533864 0.93 CYP1A2 (0.58) CYP1A2ALDH1A1HSD17B10HPGDTHRB
SCHEMBL4845687 0.93 CYP1A2 (0.58) CYP1A2ALDH1A1HSD17B10HPGDTHRB
SCHEMBL11302617 0.93 CYP1A2 (0.58) CYP1A2ALDH1A1HSD17B10HPGDTHRB
SCHEMBL2538508 0.93 CYP1A2 (0.65) CYP1A2ALDH1A1HSD17B10HPGDTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2260035-B1 POLYCYCLIC ORGANIC COMPOUNDS, POLARIZING ELEMENTS AND METHOD OF PRODUCTION THEREOF CRYSOPTIX KK (JP) 2014-08-20 EP claimed
US-20110149393-A1 Polycyclic Organic Compounds, Polarizing Elements and Method of Production Thereof Crysoptic KK (JP) 2011-06-23 US claimed
EP-2260035-A2 POLYCYCLIC ORGANIC COMPOUNDS, POLARIZING ELEMENTS AND METHOD OF PRODUCTION THEREOF CRYSOPTIX K.K. (JP) 2010-12-15 EP claimed
US-20100071717-A1 METHOD AND APPARATUS FOR CLEANING VEHICLES R. LEWIS TECHNOLOGIES, INC. (US) 2010-03-25 US claimed
WO-2009109781-A2 POLYCYCLIC ORGANIC COMPOUNDS, POLARIZING ELEMENTS AND METHOD OF PRODUCTION THEREOF CRYSOPTIX K.K. (JP) 2009-09-11 WO claimed
EP-2260035-B1 POLYCYCLIC ORGANIC COMPOUNDS, POLARIZING ELEMENTS AND METHOD OF PRODUCTION THEREOF CRYSOPTIX KK (JP) 2014-08-20 EP disclosed
US-20110149393-A1 Polycyclic Organic Compounds, Polarizing Elements and Method of Production Thereof Crysoptic KK (JP) 2011-06-23 US disclosed
EP-2260035-A2 POLYCYCLIC ORGANIC COMPOUNDS, POLARIZING ELEMENTS AND METHOD OF PRODUCTION THEREOF CRYSOPTIX K.K. (JP) 2010-12-15 EP disclosed
US-20100071717-A1 METHOD AND APPARATUS FOR CLEANING VEHICLES R. LEWIS TECHNOLOGIES, INC. (US) 2010-03-25 US disclosed
WO-2009109781-A2 POLYCYCLIC ORGANIC COMPOUNDS, POLARIZING ELEMENTS AND METHOD OF PRODUCTION THEREOF CRYSOPTIX K.K. (JP) 2009-09-11 WO disclosed
WO-2006135453-A1 METHOD AND APPARATUS FOR CLEANING VEHICLES R. LEWIS TECHNOLOGIES, INC. (US) 2006-12-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110149393-A1 Polycyclic Organic Compounds, Polarizing Elements and Method of Production Thereof CCNB1, CCNB2, CCNE2 CYP1A2 213/4885ALDH1A1 3686/4885HSD17B10 3435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.